|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Prepaid expenses - non-current | ||||||||
| Cash held in escrow account | ||||||||
| Cash and investments held in trust account | ||||||||
| Total Non-current assets | ||||||||
| Total Assets | ||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||
| Current Liabilities | ||||||||
| Accrued offering costs | ||||||||
| Accrued expenses | ||||||||
| Promissory note | ||||||||
| Nonrelated Party | ||||||||
| Third Party | ||||||||
| Related Party | ||||||||
| Total Current Liabilities | ||||||||
| Deferred underwriting commission payable | ||||||||
| Total Liabilities | ||||||||
| Ordinary shares subject to possible redemption 3,458,092 and 6,000,000 shares at a redemption value of $11.08 and $10.75 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Shareholders’ Deficit: | ||||||||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,830,000 shares issued and outstanding (excluding 3,458,092 and 6,000,000 shares subject to redemption as of June 30, 2026 and December 31, 2025, respectively) | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders’ Deficit | ||||||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
